tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ANI Pharmaceuticals raises FY25 adj. EPS view to $7.37-$7.64 from $6.98-$7.35
PremiumThe FlyANI Pharmaceuticals raises FY25 adj. EPS view to $7.37-$7.64 from $6.98-$7.35
22d ago
ANI Pharmaceuticals reports Q3 adjusted EPS $2.04, consensus $1.77
Premium
The Fly
ANI Pharmaceuticals reports Q3 adjusted EPS $2.04, consensus $1.77
22d ago
ANIP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ANIP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
24d ago
ANI Pharmaceuticals price target raised to $121 from $93 at H.C. Wainwright
PremiumThe FlyANI Pharmaceuticals price target raised to $121 from $93 at H.C. Wainwright
2M ago
ANI Pharmaceuticals price target raised to $114 from $86 at Guggenheim
Premium
The Fly
ANI Pharmaceuticals price target raised to $114 from $86 at Guggenheim
3M ago
ANI Pharmaceuticals Highlights Commercialization Focus Amid Challenges
Premium
Company Announcements
ANI Pharmaceuticals Highlights Commercialization Focus Amid Challenges
3M ago
ANI Pharmaceuticals price target raised to $94 from $80 at Piper Sandler
PremiumThe FlyANI Pharmaceuticals price target raised to $94 from $80 at Piper Sandler
4M ago
Morning Movers: Under Armour sinks following second quarter earnings
Premium
The Fly
Morning Movers: Under Armour sinks following second quarter earnings
4M ago
ANI Pharmaceuticals reports Q2 adjusted EPS $1.80, consensus $1.42
Premium
The Fly
ANI Pharmaceuticals reports Q2 adjusted EPS $1.80, consensus $1.42
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100